CareFusion reaffirmed the fiscal 2013 guidance it provided on Aug. 9 and does not believe the matter will have a meaningful impact on expected revenue, earnings or cash flow.
The matter has no impact on CareFusion customers or the underlying fundamentals and cash flows of the Pyxis business.
CareFusion will host a webcast and conference call today at 2 p.m. PDT ( 5 p.m. EDT) to discuss the matter. To access the webcast, visit the Investors page at www.carefusion.com. Log on at least 15 minutes before the call begins to register and download or install any necessary audio software.Investors and other interested parties may also access the call by dialing (866) 578-5784 within the U.S. or (617) 213-8056 from outside the U.S., and use the access code 94768570. A replay of the conference call will be available from 4 p.m. PDT ( 7 p.m. EDT) on Aug. 29 through 8:59 p.m. PDT ( 11:59 p.m. EDT) on Sept. 5 and can be accessed by dialing (888) 286-8010 in the U.S. or (617) 801-6888 internationally and using the access code 66071873. About CareFusion Corporation CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com. Cautions Concerning Forward-looking Statements The CareFusion news release and the information contained herein presents "forward-looking statements," including the company's statements regarding its accounting policies, the impact of potential changes in the company's accounting policies, the impact of potential adjustments to the company's prior financial reports, the company's timing for filing its Form 10-K, the nature of any potential adjustments to the company's financial reports, and statements regarding the company's fiscal 2013 financial guidance. The company intends forward-looking terminology such as "believes," "expects," "may," "will," "should," "anticipates," "plans," or similar expressions to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, which could cause the company's actual results to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that additional information may arise during the course of the company's lease accounting review that may require the company to make additional adjustments, the time and effort required to complete the company's discussions with the SEC, and the time and effort required to make any adjustments to the company's financial reports, if required, as well as other risks described more fully in Item 1A in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2011, which are expressly incorporated herein by reference, and other factors as may periodically be described in the company's filings with the SEC. The CareFusion news release and the information contained herein reflect management's views as of Aug. 29, 2012. Except to the limited extent required by applicable law, CareFusion undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.